These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 10107821

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effectiveness of an antibiotic cost containment measure.
    Jung B, Andrews JD.
    Can J Hosp Pharm; 1990 Jun; 43(3):116-22. PubMed ID: 10105649
    [Abstract] [Full Text] [Related]

  • 3. Impact of a two-stage intervention program on cefazolin usage at a major teaching hospital.
    Gupta S, Bachand RL, Jewesson PJ.
    Hosp Formul; 1989 Jan; 24(1):41-4, 46. PubMed ID: 10291599
    [Abstract] [Full Text] [Related]

  • 4. The effect of pharmacy intervention on aminoglycoside costs.
    Tsuyuki RT, Nakagawa RS.
    Can J Hosp Pharm; 1987 Apr; 40(2):51-6. PubMed ID: 10282090
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of a newsletter in altering physicians' prescribing patterns.
    Phillips L, Landsberg KF.
    Can J Hosp Pharm; 1986 Aug; 39(4):102-4, 108. PubMed ID: 10278468
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Therapeutic interchange of cefazolin with metronidazole for cefoxitin.
    Brown GR, Clarke AM.
    Am J Hosp Pharm; 1992 Aug; 49(8):1946-50. PubMed ID: 1442838
    [Abstract] [Full Text] [Related]

  • 10. A strategy to reduce drug expenditures with a drug utilization review program.
    Hoffmann RP.
    Hosp Pharm; 1984 Jan; 19(1):7-8, 11-2. PubMed ID: 10264746
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A targeted review of vancomycin use.
    Piquette RK.
    Can J Hosp Pharm; 1991 Apr; 44(2):83-7. PubMed ID: 10111726
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Trends in cost containment: where do we cut?
    Schneider PJ, Kilarski DJ.
    Hosp Pharm; 1981 Dec; 16(12):647-51. PubMed ID: 10253505
    [Abstract] [Full Text] [Related]

  • 18. Effect of computer-generated prompts on physician prescribing of multiple daily doses.
    Atkinson V, Andrews JD.
    Can J Hosp Pharm; 1987 Jun; 40(3):91-3. PubMed ID: 10282583
    [Abstract] [Full Text] [Related]

  • 19. Involving physicians in efforts to control pharmaceutical expenditures.
    Shulkin DJ, McGourty ME, Bourret J.
    Med Interface; 1995 Aug; 8(8):85-7, 90. PubMed ID: 10144777
    [Abstract] [Full Text] [Related]

  • 20. Washington State CARE Project: downstream cost changes associated with the provision of cognitive services by pharmacists.
    Smith DH, Fassett WE, Christensen DB.
    J Am Pharm Assoc (Wash); 1999 Aug; 39(5):650-7. PubMed ID: 10533346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.